Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06054386 · ClinicalTrials.gov registry record · NA

Attention Bias Modification Training for Social Phobia (ABMSP)

A NA study of Social Anxiety Disorder, sponsored by University of Wisconsin, Milwaukee.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06054386: Recruiting NA study of Social Anxiety Disorder, sponsored by University of Wisconsin, Milwaukee.

NCT06054386 is a NA study of Social Anxiety Disorder that is actively recruiting participants, run by University of Wisconsin, Milwaukee. The registered enrollment target is 60 participants, below the 158-participant average among 32 other Social Anxiety Disorder trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06054386, a NA study of Social Anxiety Disorder, is actively recruiting participants, sponsored by University of Wisconsin, Milwaukee.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Attentional bias has primarily been investigated as a primary cognitive etiology of social anxiety symptoms. Previous research has found that individuals with high social anxiety showed facilitated attentional engagement to threat stimuli or delayed disengagement of attention from threat. Attentional Bias Modification Training (ABMT) was developed through applying the attentional mechanism in social anxiety. During ABMT, participants are deliberately induced to shift their attention away from threat stimuli and toward neutral stimuli. Despite its proven effectiveness, a recent meta-study found that the effect size of ABMT is significant but too small. As a result, the current study focuses on improving the existing ABMT by incorporating integrative factors into attention training. The current study aims to integrate bottom-up and top-down cognitive processes in ABMT. Participants will be randomly assigned to one of two conditions (active or placebo training) and will complete the ABMT for three weeks. The ABMT's efficacy will be assessed by comparing pre- and post-training measures.

Primary Outcome

The Mini-Social Phobia Inventory (Mini-SPIN; Connor et al., 2001) is a 3-item measure which assesses the degree to which an individual experiences fear or avoidance in social situations. The measure uses a 5-point-Likert rating scale ranges from 0="not at all" to 4="extremely", with a total score range of 0-12. At a cutoff score of 6, the Mini-SPIN showed sensitivity of 89% and specificity of 90% for detecting generalized social anxiety disorder (Connor et al., 2001). The higher the scores, the

Conditions Studied

Interventions

  • OTHER Attentional Bias Modification Training (ABMT)
  • OTHER General Attention Control Training

Study Locations (1)

Wisconsin

  • University of Wisconsin-Milwaukee - Milwaukee

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2022-04-07
Est. Completion 2024-08-31
Phase NA
University of Wisconsin, Milwaukee

21 total trials

What NCT06054386 shows while recruiting

NCT06054386 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 158-participant average among 32 other Social Anxiety Disorder trials with a reported enrollment target (62% lower).

The record links to 1 condition, with Social Anxiety Disorder appearing as the primary indexed condition, and to 2 interventions - of which Attentional Bias Modification Training (ABMT) is the first listed.

NCT06054386 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT06054386 about?

NCT06054386 is a clinical study titled "Attention Bias Modification Training for Social Phobia (ABMSP)". Attentional bias has primarily been investigated as a primary cognitive etiology of social anxiety symptoms. Previous research has found that individuals with high social anxiety showed facilitated attentional engagement to threat stimuli or delayed disengagement of attention from threat. Attentiona...

What is the current status of trial NCT06054386?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2022-04-07. Estimated completion is 2024-08-31.

What conditions does trial NCT06054386 study?

This clinical trial studies the following conditions: Social Anxiety Disorder.

What interventions are being tested in trial NCT06054386?

The interventions under investigation include: Attentional Bias Modification Training (ABMT) (OTHER), General Attention Control Training (OTHER).

Who is sponsoring clinical trial NCT06054386?

This trial is sponsored by University of Wisconsin, Milwaukee, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06054386 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Social Anxiety Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06054386's enrollment target sits among peer trials

60 21st of 32 higher than 8 of 32 other Social Anxiety Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Social Anxiety Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06054386, the US trial registry maintained by the National Library of Medicine. NCT06054386 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.